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Abstract 
 
Objective(s) 
Considering fair response to inhaled corticosteroids and reports of severe air way hyper responsiveness in 
chemical warfare victims (CWV), a role for eosinophilic inflammation (i.e. asthma) was postulated. The 
objective of this study was to determine the presence of eosinophilic inflammation in CWV by evaluation of 
Sputum cellularity and eosinophil cationic protein (ECP). 
Materials and Methods 
Forty CWV and 15 control subjects entered this cross sectional study. Demographic data, dyspnea severity 
scale, spirometry results and 6 min walk test were determined. Sputum was collected with inducing by 
nebulizing hypertonic saline and analyzed for total inflammatory cell count, the cellular differential count 
and ECP level. Control group was normal volunteers with PC20 more than 8 mg/ml. 
Results 
Mean±SD of eosinophil percentage (11.7±11.1%) and ECP level in sputum of CWV (46.1±19.5 ng/ml) were 
significantly more than control group. Regression analysis showed significant correlation between ECP level 
and percentage of eosinophils in sputum (r= +0.43, P< 0.01). ECP level of CWV subjects with obstructive 
pattern did not show any significant difference from CWV with normal spirometry. ECP level in CWV 
subjects who revealed more than 12% improvement in forced expiratory volume in one second (FEV1) was 
significantly higher than CWV who had improvement less than 12% (P= 0.01). BO and asthma as final 
clinical diagnosis of CWV did not show any significant difference of sputum ECP. 
Conclusion 
Bronchial inflammation in different types of pulmonary complication of CWV is eosinophil dependent. ECP 
level of sputum in CWV could guide physician to select CWV who would respond to corticosteroids. 
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Introduction 
Sulfur mustard (SM) is a vesicant chemical 
weapon which was used widely by Iraq between 
1983 and 1988 during Iran-Iraq war. This 
chemical warfare causes delayed complications 
in organs such as lung, eyes, skin, and peripheral 
nerves (1,2). Lung lesions are the most prevalent 
(42%) of these complications (3). The most 
frequent pulmonary complications of chemical 
warfare agent occur in air ways. Early report 
during and after the Iran and Iraq war 
corroborated chronic bronchitis and 
bronchiectasis (2). But after precise 
investigation, Ghaneie and co workers proved 
that predominant pathologic and imaging 
findings in chemical warfare victims (CWV) 
was bronchiolitis obliterans (4, 5). Natural 
course of this disease is typically progressive and 
usually does not respond to treatment. But CWV 
usually managed with high dose inhaled 
corticosteroids (ICS) and long acting beta 2 
agonists. In another study, Ghanei et al treated 
CWV with systemic corticosteroids (6). These 
results raised the question that: Does pulmonary 
lesions of chemical warfare cause eosinophil 
dependent lung lesion such as asthma? Previous 
reports showed that airway hyper responsiveness 
was found to be present in 75% of CWV (7). In 
fact in our experience there is a group of CWV 
who were asymptomatic for a period of time 
after their exposure and then presented with 
asthma symptoms that partially responded to 
ICS therapy. 
The aim of this study was to determine the 
presence of eosinophilic inflammation by 
evaluating the cellularity of sputum and 
eosinophil cationic protein (ECP) to prove the 
presence of eosinophilic inflammation in CWV. 
 
Materials and Methods 
Subjects 
Forty CWV entered this study. All had proved 
history of exposure to chemical weapons such as 
sulfur mustard or nerve agents and experienced 
skin symptoms after exposure for a period of 
time. These subjects suffered from obstructive 
lung disease such as asthma or bronchiolitis 
obliterance and for this reason they were treated 
with ICS (beclomethasone dipropionate or 
fluticasone dipropionate) 300-1000 µg/day for  
3-15 years. Additional drugs like short or long 
acting inhaled beta 2 agonists such as salbutamol 
or salmetrol were also used.  
Control group was 15 normal subjects who 
didn’t have any complaint of respiratory 
symptoms and in methacholine challenge test 
their PC20 (Provocation concentration 
producing a 20% fall in forced expiratory 
volume in one second (FEV1)) was more than 8 
mg/ml. The body mass index (BMI), age, and 
sex were matched with case group. All the case 
and control subjects were male, nonsmokers 
who didn’t consume any systemic steroids. 
Subjects with peripheral blood eosinophilia or 
other known eosiniphilic disease were also 
excluded. 
The experiments were approved by the Ethical 
Committee of Mashhad University of Medical 
Sciences, Mashhad, Iran and each subject gave 
an informed consent. 
 
Technique and protocol 
The study was designed as prospective, case 
control study, and performed in pulmonary 
function laboratory of the Ghaem hospital, 
Mashhad, Iran (2007-2008). A questionnaire 
regarding the respiratory symptoms was 
designed and completed. Severity of dyspnea 
was evaluated by Modified Medical Research 
Council score (MMRC) questionnaire.  
 
Spirometry and imaging 
At the beginning of each collection of 
specimen, standard spirometry was performed 
using a standard spirometer (Chest Inc, Tokyo 
Japan). Before spirometery, the operator 
demonstrated the required maneuver, and 
subjects were encouraged and supervised 
throughout test performance. Main variables 
measured consisted of forced vital capacity 
(FVC), FEV1 and FEV1/FVC. Measurements 
of these variables were performed using the 
acceptability standards outlined by the 
American Thoracic Society (ATS) (8), in a 
sitting position inside the box and wearing 
nose clips. Values were expressed as 
percentage of the predicted values. Response 
to bronchodilator was assessed by prescribing 
400 µg of salbutamol inhaler via spacer and 
the FVC maneuver was repeated. Severities of 
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obstructive lung disease were classified 
according to American Thoracic Society 
recommendations to mild (FEV1 60-80% 
predicted), moderate (40-59% predicted) and 
severe (less than 40% predicted) disease (9). 
Type and dose of ICS were recorded and 
considered for evaluation in case group. Daily 
steroid dosage was classified according to 
Global Initiative for Asthma guideline (10). 
Exercise tolerance was evaluated by 6 min 
walk test (6MWT). High resolution computed 
tomograpghy (HRCT) of lung in mediastinal 
and paranchymal windows in deep inspiration 
and expiration were used to classify specific 
disease. Final diagnosis was made by using 
clinical findings, spirometry and HRCT. 
 
Collecting sputum specimen 
Before procedure, 400 µg salbutamol was 
delivered to CWV via a large spacer to prevent 
bronchospasm. Inducing sputum was performed 
by nebulizing hypertonic saline (nebulizer used 
was Omron NE -U17   ). The concentration of 
used saline was 3%, 4% and 5% and subjects 
had 5 min rest between each step. In each step 
subjects could expectorate enough sputum. By 
the end of procedure the specimens were sent to 
laboratory in less than two hours. 
 
Sputum processing 
The saliva contamination of sputum was 
winnowed by sampler, and the volume of the 
samples was measured by graduated cup. For 
homogenization, the specimen was transferred 
to a petri dish and was treated by adding four 
times volumes of 0.1% dithiotheritol (DTT) 
(sputolysin 10%; Calbiochem corp.; San 
Diego, CA). The petri dish was placed on a 
rotator mixer for 15 min to ensure complete 
homogenization. To remove cell debris and 
mucus, the suspensions were filtered through 
48 µm nylon gauze (B&SH Thompson, 
Scarbough, Ontario, Canada); for preserving 
bronchial cells. The resulting suspension was 
centrifuged at 1400 g for 10 min at 4 °C. The 
supernatant was aspirated and were frozen at -
24 °C for subsequent measurement of ECP.  
The cell suspension was aspirated and 
adjusted to one milliliter by PBS buffer. 
Homogenized sputum was used to determine 
the total cell count with a standard 
hemocytometer. For cell type determination, 
two smears of the unfixed sputum were 
prepared (air-dried) and stained by the 
hematoxylin & eosin. Three hundred non-
squamous cells were counted in each slide. 
The mean of results of two slides were 
recoded. The samples with more than 20% 
squamous cells were considered as 70% 
contaminated with saliva and samples with 
more than 42% squamous cells were 
considered as more than 80% contaminated 
(11). Sputum with more than 42% squamous 
cells was excluded from study. As a control, 
comparison of CWV and control groups by chi 
square method showed that frequency of 
sputum contamination was not significant 
different in two groups (χ2= 0.32, P= 0.84). 
The concentration of ECP was determined 
using an ELISA kit (MBL Co.LTD; Naka-ka 
Nagoya, Japan. Code No.7618E). The lowest 
detection limit was 2 µg/l.  
 
Statistical analysis 
Sample size was calculated according to 5% 
alpha error, 80% power and 2/1 ratio of control 
to case group (40 CWV and 15 control subjects). 
Kolmogerov- Smirnof test was done for 
evaluating the homogeneity of samples and 
nonparametric tests was used when the data 
showed no homogenous pattern. Mean values 
for age, spirometric data and ECP level were 
quoted as arithmetic mean and standard 
deviation (SD). For comparing values of 
spirometric data and ECP between normal and 
chemical war victims unpaired “t” test was used. 
Analysis of variance was used to test differences 
between the CWV severity groups. Statistical 
significance was accepted at P< 0.05. 
 
Results 
General data 
Forty CWV with average age of 47.80±10.3 
years (range 35-78) were enrolled in this study. 
Control group were 15 subjects with average age 
of 40±13.7 years (range 18-62) (Table 1). 
The most frequent clinical findings were 
dyspnea (in all CWV) followed by cough in 38 
subjects (95%). Hemoptysis was presented in 
3 (7.5%) CWV. Physical exam showed 
Majid Mirsadraee et al 
          Iran J Basic Med Sci, Vol. 14, No. 3, May-June   2011 252
wheezing in 13 CWV (33.3%) and rales in 5 
CWV (12.8%). 
 
Spirometry results 
The most frequent spirometry pattern in CWV 
group was obstructive in 27 subjects, however 
normal spirometry and restrictive pattern were 
also detected in 6 and 3 cases respectively. 
Spirometry data in obstructive group of CWV 
showed low level of FVC percentage of 
predicted (62±14%) and FEV1 percentage of 
predicted (52±15%) (Table 1). Significant 
improvement in FEV1 after bronchodilator 
was seen in only 6 cases of CWV group. 
 
Cellularity of sputum 
Five specimen of CWV and one specimen of 
control group were excluded from study for the 
reason that mucoid part of sputum was absent. 
Mean±SD of total inflammatory cells in CWV 
was 1465±2354 cells per ml that did not show 
significant difference from control group (Table 
1). Mean±SD of eosinophilwas 11.7±11.1 % that 
was significantly more than control group (P= 
0.02), in comparison lymphocyte in control 
group was significantly more than CWV group 
(Table 2). Neutrophile, macrophage and 
epithelial cells were not significantly different 
between groups. Approximately half of the cases 
in both groups showed epithelial cells less than 
21% and less than 27% showed epithelial cells 
more than 42%. 
 
ECP level in sputum 
ECP level in sputum of CWV was 46.1±19.5 
ng/ml that was significantly more than control 
group (Table 1). Eighty five percent of CWV 
subjects showed ECP level more than mean 
ECP level of control group. Twenty five 
CWVsubjects with obstructive pattern in 
spirometry revealed ECP level more than 45 
ng/ml and in 5 subjects ECP was less than this 
level. Regression analysis showed significant 
correlation between ECP level and percentage 
of eosinophilin sputum (r= +0.43, P< 0.01) 
(Figure 1). On the contrary regression analysis 
did not show any significant correlation 
between FEV1 and ECP level (r= 0.12,              
P= NS). ECP level of CWV subjects who 
showed obstructive pattern was 46±2.4 ng/ml 
that did show any significant difference from 
CWV with normal spirometry (47.2±19.5 
ng/ml, t= 0.2, P= 0.98). 
According to response to bronchodilator and 
improvement in FEV1, CWV subjects were 
categorized into two groups: 1- responder 
(asthma like) 2- non responder (COPD or 
bronchiolitis like). Comparison of sputum 
differential cell count did not show any 
significant difference between eosinophil and 
neutrophil percentage in these two groups. 
However, ECP level in bronchodilator 
responder group was significantly higher than 
non-responder group (P= 0.01). 
Final diagnosis of pulmonary complication 
of CWV was established according to 
spirometry and HRCT findings. Although 
higher levels of eosinophlie count seem to be 
presented in asthma groups but statistical 
analysis showed not significant difference 
between groups (Table 3). 
Mean of 6MWT in CWV was 351±99 m. 
Statistical analysis showed correlation of 6MWT 
and sputum eosinophil and ECP levels were not 
significant. Dyspnea scale revealed that stage 2 
of MMRC had the highest frequency (45%) 
followed by stage 3 (25%). Stage 1 and 4 
consisted only 21% and 9% of CWV (none for 
stage 5). Mean of eosinophilcount and sputum 
ECP were not significantly different in MMRC 
different stages. The correlation of MMRC and 
sputum ECP and eosinophilcount was evaluated 
and did not show any significant correlation 
(Table 4). 
 
 
 
Figure 1. Correlations between sputum ECP and sputum 
eosinophilia in mustard gas lung injured patients and 
healthy control groups. 
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Table 1. Comparison of major demographic, spirometric data, cellularity and eosinophilic cationic protein (ECP) 
between chemical warfare victims (CWV) and normal control groups. 
 
 
 
 
 
Table 2. Comparison of sputum volume, cellurity and eosinophilic cationic protein (ECP) between chemical warfare 
victims (CWV)  and normal control groups. 
 
 CWV Control P value 
Volume (µl) 974±897 1000±781 0.92 
Total cells (count per ml) 1965±2354 1360±1325 0.62 
Eosinophil(%) 11.7±11.1 4.2±5.9 0.04 
Neutrophil(%) 16.5±10.8 16.7±16.9 0.97 
Lymphocyte (%) 6.6±6.5 11.1±6.8 <0.01 
Macropage (%) 67.1±19.8 68.8±19.1 0.8 
Epithelial cell (%) 25.2±17.5 27±8.5 0.75 
ECP (ng/ml) 46.1±19.5 23.6±19.5 0.001 
 
 
 
Table 3. Comparison of sputum eosinophil(percentage and total) and eosinophilic cationic protein (ECP) in specific lung 
disease of chemical warfare victims (CWV)  groups. 
 
 
 
 
Table 4. Correlation of sputum eosinophilic cationic protein (ECP) and eosinophilwith 6MWT and MMRC. 
 
 
 
 
 
 
 
 
 
 
Discussion 
This study was conducted on CWV who 
suffered from long lasting pulmonary disease. 
The main anticipated differential diagnoses 
were bronchiolitis obliteranse, asthma, 
bronchiectasis and chronic bronchitis (2, 4). 
Pulmonary function test mostly showed 
obstructive pattern that can be considered for 
all the differential diagnosis mentioned above. 
BO was observed in 44% of CWV 80% of 
whom revealed high eosinophilpercentage and 
ECP levels.  Six subjects revealed normal 
spirometry who their ECP levels were high 
that can be classified as mild asthma. Five 
subjects revealed low sputum ECP levels and 
was classified as BO. Also, three subjects 
showed restrictive pattern, according to HRCT 
two subjects proved to suffer from IPF. Both 
of these subjects showed high level of 
 Age 
Yrs 
Sex 
M/F 
FEV1 
% pred 
FEV1/FVC 
% 
Sputum ECP 
µg/ml 
Sputum eosinophile 
cells/mm3 
 
CWV 
(N=40) 
47.8±10.3 
(35-78) 
40/0 59.2±18 
(27-105) 
64.1±13.4 
(33-91) 
46.1±19.5 
(2-72) 
229±490 
(2-2304) 
Normal 
(N=15) 
40±13.7 
(18-62) 
8/7 90.5±30.1 
(63-118) 
101.0±18.6 
(84-118) 
23.6±19 
(1.2-60) 
64±73.6 
(1-250) 
P value 0.19 <0.0001 <0.0001 0.001 0.001 0.02 
 Eosinophilpercentage Eosinophilcount ECP (ng/ml) High ECP 
(>45 ng/ml) 
BO 12±13 207±418 47±19 80% 
Asthma 14±10 444±752 42±22 70% 
Brronchiectasis 4.5±3.5 45±55 52±10 100% 
Interstitial Fibrosis 11±10 42±51 53±6.7 100% 
 6MWT MMRC 
 R P value R P value 
ECP +0.16 0.4 +0.26 0.17 
Eosinophil -0.12 0.3 +0.31 0.12 
Majid Mirsadraee et al 
          Iran J Basic Med Sci, Vol. 14, No. 3, May-June   2011 254
eosinophiland ECP. Due to normal HRCT, the 
remainder of the cases was classified as 
asthma that were not very cooperative during 
spirometry. Response to bronchodilator was 
helpful to diagnosis asthma in only 6 subjects. 
Totally we conclude that from 36 CWV 
subjects, 16 subjects should have suffered 
from BO and 15 subjects suffered from 
asthma. High Sputum ECP was found in 
fraction of subjects of all groups. 
For differentiating between asthma and 
chronic airway disease such as bronchiolitis 
obliteranse and COPD, several devices were 
used. One of them is spirometry and especially 
improvement of FEV1 after using 
bronchodilator. In this regard every subject 
who showed more than 12% increase in FEV1 
or FVC classified as asthma (9). But in severe 
longstanding asthma with remodeling of 
bronchial structure, reversibility of air way 
obstruction may decrease, the term that we 
called "Irreversible asthma" (12). Therefore 
asthma cannot be ruled out in subjects who do 
not improve post bronchodilator use. 
Bronchodilator response was evaluated in 22 
subjects of this study. Eighteen cases (82%) of 
these subjects did not significantly improve 
with bronchodilator, although all of them 
showed high level of sputum ECP. 
High resolution computed tomography 
(HRCT) of lung especially when comparing 
inspiration and deep expiration imaging is 
another helpful study for diagnosis of 
bronchiolitis obliteranse, COPD (emphysema) 
and bronchiectasis. Results of previous study 
on HRCT of CWV showed air trapping, 
bronchial thickening and bronchial dilatation 
(4). In this report micronodular pattern was not 
seen. These pictures were also described in 
severe resistant asthma with airway 
remodeling (13, 14). As a result, using HRCT 
for differentiating asthma from bronchiolitis 
obliteranse is not very helpful. 
In this study we used sputum for defining the 
pattern of bronchial inflammation in CWV. 
Collecting sputum by inducing sputum was 
very effective and without complication. 
Increasing ECP level was also detected in 
obstructive lung disease other than asthma. In 
a study on COPD patients, ECP level was 
detected up to 22±6 µg/l (15). In another study 
on lung transplant recipients who suffered 
from BO, ECP in BALF was in the range of   
0-200 µg/l (median 40). In this study the 
eosinophilic count in BALF was low or zero. 
Analysis of sputum obtained by induced 
sputum in IPF also showed 2.1% 
eosinophiland elevated ECP (median 1.1 
mg/ml) (16). In this study the authors 
suggested that the eosinophiles were 
originated from airways and cough symptoms 
in subjects showed eosinophilia and/or 
elevated ECP in sputum may respond to 
steroids better than other IPF patients. In our 
series 2 subjects showed IPF and both revealed 
high level of ECP which could get benefit 
from steroids. 
 However this study showed that 85% of 
CWV demonstrate high level of sputum ECP 
in favor of eosiniphilic inflammation in air 
ways. This finding is not related to type of 
lung disease. We believe that eosinophilic 
inflammation is the result of chemical injury 
occurred in air ways. Fortunately inhaled 
corticosteroid and other steroids could 
suppress eosinophilic inflammation and may 
be useful for management of CWV. According 
to the results of this study 82% of CWV did 
not showed post bronchodilator response, so 
this test can not be used for differentiation 
between asthma and BO. Therefore sputum 
ECP can help physician to classified CWV to 
eosinophilic dependent CWV and non 
eosinophilic dependent CWV (regardless of 
type of pulmonary lesion). In CWV who suffer 
from eosinophilic inflammation, treatment 
with corticosteroids could be very effective. 
Other subjects with low ECP may benefit from 
long term treatment with Macrolids or 
immunosuppressive drug (17, 18).  
Unfortunately ECP level did not reveal any 
correlation with MMRC, 6MWT or FEV1. 
Therefore pulmonary complication of CWV 
should be a little bit different from routine 
asthma and ECP level can not be used for 
evaluating the severity of pulmonary 
complication of CWV.  
 
Conclusion 
According to categorization through sputum 
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eosinophiland ECP, most of CWV suffer from 
eosinophilic inflammation in lung (including 
asthma). In addition to spirometry and HRCT, 
sputum ECP can be recommended for 
diagnosis, classification and directing 
corticosteroid therapy for pulmonary 
complication of chemical weapon. 
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